10.20 USD
↘ 0.16 (1.54%)AT CLOSE (11:59 AM EDT)
Kazia Therapeutics Limited American Depositary Shares
KZIANASDAQ • USD
10.27
↗ 0.07 (0.71%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
10.27
↗ 0.07 (0.71%)
Market: CLOSED
KZIA is currently priced at $10.18. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. This is driven by a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Sep 16, 2026.
Open?$10.50
High?$10.97
Low?$10.15
Prev. Close?$10.36
Volume?353.8K
Avg. Volume?N/A
VWAP?$10.48
Bid / Ask
Bid?$8.90 × 100
Ask?$12.28 × 100
Spread?$3.38
Midpoint?$10.59
Valuation & Ratios
Market Cap?161.1M
Shares Out?13.0M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
Themes
Employees
6
Market Cap
161.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1999-01-06
Address
140 WICKS RD
NEW SOUTH WALES 2113, C3 2113
Phone: 01161298780088
NEW SOUTH WALES 2113, C3 2113
Phone: 01161298780088
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short Interest?905.8K
Days to Cover?2.9
Avg Daily Volume309.4K
Settlement Date2026-08-31